FR2494112B1 - - Google Patents

Info

Publication number
FR2494112B1
FR2494112B1 FR8024568A FR8024568A FR2494112B1 FR 2494112 B1 FR2494112 B1 FR 2494112B1 FR 8024568 A FR8024568 A FR 8024568A FR 8024568 A FR8024568 A FR 8024568A FR 2494112 B1 FR2494112 B1 FR 2494112B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8024568A
Other languages
French (fr)
Other versions
FR2494112A1 (enrdf_load_stackoverflow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR8024568A priority Critical patent/FR2494112B1/fr
Priority to BE1/10357A priority patent/BE891129A/fr
Priority to NL8120434A priority patent/NL8120434A/nl
Priority to PCT/FR1981/000148 priority patent/WO1982001649A1/fr
Priority to EP81903096A priority patent/EP0065531A1/fr
Priority to AT0906481A priority patent/AT387517B/de
Priority to DE19813152519 priority patent/DE3152519C2/de
Priority to IT25185/81A priority patent/IT1144948B/it
Publication of FR2494112A1 publication Critical patent/FR2494112A1/fr
Application granted granted Critical
Publication of FR2494112B1 publication Critical patent/FR2494112B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
FR8024568A 1980-11-19 1980-11-19 Expired FR2494112B1 (enrdf_load_stackoverflow)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR8024568A FR2494112B1 (enrdf_load_stackoverflow) 1980-11-19 1980-11-19
BE1/10357A BE891129A (fr) 1980-11-19 1981-11-16 Nouvelle forme galenique du fenofibrate, son procede d'obtention son application comme medicament
PCT/FR1981/000148 WO1982001649A1 (fr) 1980-11-19 1981-11-18 Nouvelle forme galenique du fenofibrate, son procede d'obtention, son application comme medicament
EP81903096A EP0065531A1 (fr) 1980-11-19 1981-11-18 Nouvelle forme galenique du fenofibrate, son procede d'obtention, son application comme medicament
NL8120434A NL8120434A (nl) 1980-11-19 1981-11-18 Nieuwe galenische vorm van fenofibraat, werkwijze ter bereiding alsmede de geneeskundige toepassing daarvan.
AT0906481A AT387517B (de) 1980-11-19 1981-11-18 Verfahren zur herstellung eines praeparates von para-aroyl-phenoxy-isobuttersaeurederivaten
DE19813152519 DE3152519C2 (de) 1980-11-19 1981-11-18 Neues Fenofibrat-Fertigpr{parat mit verz¦gerter Wirkstofffreisetzung
IT25185/81A IT1144948B (it) 1980-11-19 1981-11-19 Nuova forma galenica del fenofibrato, suo processo per ottenerla, sua applicazione come medicinale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8024568A FR2494112B1 (enrdf_load_stackoverflow) 1980-11-19 1980-11-19

Publications (2)

Publication Number Publication Date
FR2494112A1 FR2494112A1 (enrdf_load_stackoverflow) 1982-05-21
FR2494112B1 true FR2494112B1 (enrdf_load_stackoverflow) 1986-01-10

Family

ID=9248140

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8024568A Expired FR2494112B1 (enrdf_load_stackoverflow) 1980-11-19 1980-11-19

Country Status (8)

Country Link
EP (1) EP0065531A1 (enrdf_load_stackoverflow)
AT (1) AT387517B (enrdf_load_stackoverflow)
BE (1) BE891129A (enrdf_load_stackoverflow)
DE (1) DE3152519C2 (enrdf_load_stackoverflow)
FR (1) FR2494112B1 (enrdf_load_stackoverflow)
IT (1) IT1144948B (enrdf_load_stackoverflow)
NL (1) NL8120434A (enrdf_load_stackoverflow)
WO (1) WO1982001649A1 (enrdf_load_stackoverflow)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2554718B1 (fr) * 1983-11-14 1986-04-04 Ethypharm Sa Nouvelles formes galeniques du sulpiride utilisables par voie orale
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale
JPS60221078A (ja) * 1984-04-18 1985-11-05 Morinaga Milk Ind Co Ltd 有用微生物粉末の粒状製品およびその製造法
IT1180507B (it) * 1984-06-29 1987-09-23 Roberto Valducci Procedimento per la preparazione di etofibrato o sostanze di pari o simili caratteristiche, in microgunuli-ritardo e prodotto ottenuto con tale procedimento
FR2602423B1 (fr) * 1986-08-08 1989-05-05 Ethypharm Sa Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
FR2737121B1 (fr) * 1995-07-27 1997-10-03 Cl Pharma Nouvelles formulations galeniques du fenofibrate et leurs applications
DE19608750A1 (de) * 1996-03-06 1997-09-11 Durachemie Gmbh & Co Kg Verfahren zur Herstellung von Fenofibrat-Präparaten
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
FR2758461A1 (fr) * 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
US7014864B1 (en) 1998-12-18 2006-03-21 Abbott Laboratories Formulations comprising lipid-regulating agents
US6814977B1 (en) 1998-12-18 2004-11-09 Abbott Laboratories Formulations comprising lipid-regulating agents
US6838091B2 (en) 1998-12-18 2005-01-04 Abbott Laboratories Formulations comprising lipid-regulating agents
DE19858789A1 (de) 1998-12-18 2000-06-21 Bayer Ag Kombination von Cerivastatin und Fibraten
US6383517B1 (en) 1999-01-29 2002-05-07 Abbott Laboratories Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
US6180138B1 (en) 1999-01-29 2001-01-30 Abbott Laboratories Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
US6368622B2 (en) 1999-01-29 2002-04-09 Abbott Laboratories Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption
US6719999B2 (en) 1999-03-31 2004-04-13 Abbott Laboratories Formulations comprising lipid-regulating agents
US6465011B2 (en) 1999-05-29 2002-10-15 Abbott Laboratories Formulations comprising lipid-regulating agents
US6372251B2 (en) 1999-06-11 2002-04-16 Abbott Laboratories Formulations comprising lipid-regulating agents
US6982281B1 (en) 2000-11-17 2006-01-03 Lipocine Inc Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
FR2795961B1 (fr) 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US7863331B2 (en) 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
US6531158B1 (en) 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
FR2819720B1 (fr) 2001-01-22 2004-03-12 Fournier Lab Sa Nouveaux comprimes de fenofibrate
ME00145B (me) 2001-01-26 2010-10-10 Merck Sharp & Dohme Upotreba supstituisanih jedinjenja azetidinona za lečenje sitosterolemije
MXPA03006725A (es) 2001-01-26 2003-10-24 Schering Corp Combinaciones de activadores del receptor de activacion de proliferacion peroxisomal (ppar) e inhibidores de absorcion de esterol, y tratamiento para indicaciones vasculares.
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
DK1429756T3 (da) 2001-09-21 2007-03-19 Schering Corp Behandling af xanthoma med azetidinonderivater som sterolabsorptionsinhibitorer
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
AU2003263480A1 (en) * 2002-09-24 2004-04-19 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of fenofibrate having high bioavailability
US20040092499A1 (en) 2002-11-06 2004-05-13 Schering Corporation Methods and therapeutic combinations for the treatment of autoimmune disorders
KR100662971B1 (ko) * 2002-11-22 2006-12-28 메이지 세이카 가이샤 리미티드 입상 조성물 및 그 제조 방법
EP1829541A1 (en) * 2002-12-17 2007-09-05 Abbott GmbH & Co. KG Formulation comprising fenofibric acid or a physiologically acceptable salt thereof
CA2510261A1 (en) * 2002-12-17 2004-07-01 Abbott Gmbh & Co. Kg Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
EP1601668B1 (en) 2003-03-07 2008-08-27 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
CA2517572C (en) 2003-03-07 2011-12-13 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
CN1756755A (zh) 2003-03-07 2006-04-05 先灵公司 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
CA2531097C (en) * 2003-07-02 2012-10-09 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
EP1785133A1 (en) 2005-11-10 2007-05-16 Laboratoires Fournier S.A. Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy
WO2008075320A2 (en) * 2006-12-21 2008-06-26 Ranbaxy Laboratories Limited Antilipidemic pharmaceutical compositions and process for preparation thereof
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
CA3107214A1 (en) 2018-07-20 2020-01-23 Lipocine Inc. Liver disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2963402A (en) * 1955-01-18 1960-12-06 Nysco Lab Inc Sustained release medicament
FR1347413A (fr) * 1963-01-29 1963-12-27 Italnysco S P A Sphérules ou globules à action étalée et procédé pour leur préparation
GB1415295A (en) * 1971-10-14 1975-11-26 Orchimed Sa Substituted phenoxy-alkyl-carboxylic acids and derivatives thereof
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
FR2313915A1 (fr) * 1976-01-26 1977-01-07 Corneille Gilbert Nouvelle forme galenique d'administration de la vincamine et de ses derives, son procede de preparation et medicaments comprenant cette nouvelle forme
LU77353A1 (enrdf_load_stackoverflow) * 1977-05-16 1979-01-19
FR2432313A1 (fr) * 1978-08-01 1980-02-29 Foulhoux Pierre Nouvelle forme galenique de la betahistine et son procede d'obtention

Also Published As

Publication number Publication date
IT1144948B (it) 1986-10-29
WO1982001649A1 (fr) 1982-05-27
FR2494112A1 (enrdf_load_stackoverflow) 1982-05-21
EP0065531A1 (fr) 1982-12-01
DE3152519C2 (de) 1990-11-22
NL8120434A (nl) 1982-10-01
IT8125185A0 (it) 1981-11-19
BE891129A (fr) 1982-05-17
ATA906481A (de) 1988-07-15
AT387517B (de) 1989-02-10
DE3152519T1 (de) 1983-12-29

Similar Documents

Publication Publication Date Title
FR2473180B1 (enrdf_load_stackoverflow)
FR2473404B1 (enrdf_load_stackoverflow)
FR2473245B1 (enrdf_load_stackoverflow)
FR2473337B1 (enrdf_load_stackoverflow)
FR2473185B1 (enrdf_load_stackoverflow)
FR2473464B1 (enrdf_load_stackoverflow)
FR2472937B1 (enrdf_load_stackoverflow)
FR2473132B1 (enrdf_load_stackoverflow)
FR2474076B1 (enrdf_load_stackoverflow)
FR2473496B1 (enrdf_load_stackoverflow)
FR2472929B1 (enrdf_load_stackoverflow)
FR2480878B1 (enrdf_load_stackoverflow)
FR2473700B1 (enrdf_load_stackoverflow)
FR2474036B1 (enrdf_load_stackoverflow)
FR2473975B1 (enrdf_load_stackoverflow)
FR2473029B3 (enrdf_load_stackoverflow)
FR2488453B1 (enrdf_load_stackoverflow)
FR2473157B3 (enrdf_load_stackoverflow)
FR2473538B1 (enrdf_load_stackoverflow)
FR2473401B1 (enrdf_load_stackoverflow)
FR2474055B1 (enrdf_load_stackoverflow)
FR2473886B1 (enrdf_load_stackoverflow)
DE3148629T1 (enrdf_load_stackoverflow)
DK29281A (enrdf_load_stackoverflow)
DE3029945C2 (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
TP Transmission of property
TP Transmission of property